High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3.

Saved in:
Bibliographic Details
Title: High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3.
Authors: De Nardo D; 1] Institute of Innate Immunity, University Hospitals, Biomedical Centre, University of Bonn, Bonn, Germany. [2]., Labzin LI; 1] Institute of Innate Immunity, University Hospitals, Biomedical Centre, University of Bonn, Bonn, Germany. [2]., Kono H; Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan., Seki R; Department of Clinical Laboratory Science, Teikyo University Faculty of Medical Technology, Tokyo, Japan., Schmidt SV; Life and Medical Sciences Institute, University of Bonn, Bonn, Germany., Beyer M; Life and Medical Sciences Institute, University of Bonn, Bonn, Germany., Xu D; 1] Monash Institute of Medical Research, Monash University, Melbourne, Victoria, Australia. [2] Institute of Ageing Research, Hangzhou Normal University School of Medicine, Hangzhou, China., Zimmer S; Department of Medicine/Cardiology, University of Bonn, Bonn, Germany., Lahrmann C; Department of Medicine/Cardiology, University of Bonn, Bonn, Germany., Schildberg FA; Institutes of Molecular Medicine and Experimental Immunology, University of Bonn, Bonn, Germany., Vogelhuber J; Institute of Innate Immunity, University Hospitals, Biomedical Centre, University of Bonn, Bonn, Germany., Kraut M; Life and Medical Sciences Institute, University of Bonn, Bonn, Germany., Ulas T; Life and Medical Sciences Institute, University of Bonn, Bonn, Germany., Kerksiek A; Institute for Clinical Chemistry and Clinical Pharmacology, University of Bonn, Bonn, Germany., Krebs W; Life and Medical Sciences Institute, University of Bonn, Bonn, Germany., Bode N; Department of Medicine/Cardiology, University of Bonn, Bonn, Germany., Grebe A; Institute of Innate Immunity, University Hospitals, Biomedical Centre, University of Bonn, Bonn, Germany., Fitzgerald ML; Lipid Metabolism Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Hernandez NJ; Lipid Metabolism Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Williams BR; Monash Institute of Medical Research, Monash University, Melbourne, Victoria, Australia., Knolle P; 1] Institutes of Molecular Medicine and Experimental Immunology, University of Bonn, Bonn, Germany. [2] Institute of Molecular Immunology, Technical University of Munich, Munich, Germany., Kneilling M; 1] Department of Dermatology, Eberhard Karls University, Tuebingen, Germany. [2] Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University, Tuebingen, Germany., Röcken M; Department of Dermatology, Eberhard Karls University, Tuebingen, Germany., Lütjohann D; Institute for Clinical Chemistry and Clinical Pharmacology, University of Bonn, Bonn, Germany., Wright SD; Cardiovascular Therapeutics, CSL Limited, Parkville, Australia., Schultze JL; 1] Life and Medical Sciences Institute, University of Bonn, Bonn, Germany. [2]., Latz E; 1] Institute of Innate Immunity, University Hospitals, Biomedical Centre, University of Bonn, Bonn, Germany. [2] Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, Massachusetts, USA. [3] German Center for Neurodegenerative Diseases, Bonn, Germany. [4].
Source: Nature immunology [Nat Immunol] 2014 Feb; Vol. 15 (2), pp. 152-60. Date of Electronic Publication: 2013 Dec 08.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature America Inc Country of Publication: United States NLM ID: 100941354 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1529-2916 (Electronic) Linking ISSN: 15292908 NLM ISO Abbreviation: Nat Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1529-2916
DOI:10.1038/ni.2784